Literature DB >> 32706156

Direct-to-consumer genetic testing companies tell their customers to 'see a genetic counselor'. How do genetic counselors feel about direct-to-consumer genetic testing?

Vicky Hsieh1, Tamara Braid2, Erynn Gordon3, Laura Hercher4.   

Abstract

Professional societies, the FDA, and many direct-to-consumer genetic testing (DTC-GT) companies have highlighted the value of counseling from a medical professional with genetics expertise in order to enhance the value and minimize the risks associated with DTC-GT. However, there is limited information available identifying genetic counselors' own views on DTC-GT, their willingness to counsel consumers based on DTC-GT results, and their experiences to date seeing DTC-GT consumers in a clinical setting. We surveyed genetic counselors accessed through mailing lists associated with the National Society of Genetic Counselors (NSGC) and the American Board of Genetic Counseling (ABGC). Response rate was estimated to be 12.2% (n = 482). A majority of all respondents (56.4%, n = 263) described themselves as feeling negatively or very negatively toward DTC-GT; only 6.9% (n = 32) described themselves as feeling positively or very positively. While 90.9% of respondents (n = 398) believed that DTC-GT would be improved with the involvement of genetic counselors, only 31.2% agreed or strongly agreed that they are comfortable providing counseling to DTC-GT consumers (n = 142). Clinical counseling of DTC-GT consumers is not routine but it is also not uncommon; 40.1% of all respondents (n = 189) have seen at least one consumer in clinic for the sole purpose of reviewing DTC-GT results. The results of our study suggest that most respondents would be more accepting of DTC-GT if genetic counseling was a part of the process, but the majority of counselors do not feel comfortable providing this service.
© 2020 National Society of Genetic Counselors.

Entities:  

Keywords:  23andMe; DTC-GT; direct-to-consumer genetic testing; genetic counseling; personal genomics

Year:  2020        PMID: 32706156     DOI: 10.1002/jgc4.1310

Source DB:  PubMed          Journal:  J Genet Couns        ISSN: 1059-7700            Impact factor:   2.537


  6 in total

1.  Direct-to-consumer genetic testing in the news: a descriptive analysis.

Authors:  Corey H Basch; Grace C Hillyer; Lalitha Samuel; Erela Datuowei; Betty Cohn
Journal:  J Community Genet       Date:  2022-10-14

2.  Ethical concerns relating to genetic risk scores for suicide.

Authors:  Anna Docherty; Brent Kious; Teneille Brown; Leslie Francis; Louisa Stark; Brooks Keeshin; Jeffrey Botkin; Emily DiBlasi; Doug Gray; Hilary Coon
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2021-09-01       Impact factor: 3.568

3.  The symptom discounting effect: what to do when negative genetic test results become risk factors for alcohol use disorder.

Authors:  Woo-Kyoung Ahn; Annalise M Perricone
Journal:  Sci Rep       Date:  2022-03-04       Impact factor: 4.379

Review 4.  Development of customized inner beauty products and customized cosmetics apps according to the use of NRF2 through DTC genetic testing after the COVID-19 pandemic.

Authors:  Jinkyung Lee; Ki Han Kwon
Journal:  J Cosmet Dermatol       Date:  2022-04-24       Impact factor: 2.189

Review 5.  Direct-to-consumer genetic testing: an updated systematic review of healthcare professionals' knowledge and views, and ethical and legal concerns.

Authors:  Michelle Fernandes Martins; Logan T Murry; Liesl Telford; Frank Moriarty
Journal:  Eur J Hum Genet       Date:  2022-10-12       Impact factor: 5.351

6.  Health and kinship matter: Learning about direct-to-consumer genetic testing user experiences via online discussions.

Authors:  Zhijun Yin; Lijun Song; Ellen W Clayton; Bradley A Malin
Journal:  PLoS One       Date:  2020-09-08       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.